APIC announces winner of first Healthcare Administrator Award

October 19, 2009

Deborah Friberg, Chief Operating Officer and Executive Vice President of WakeMed Health and Hospitals, Raleigh, North Carolina, has been named the recipient of the first annual Healthcare Administrator Award, presented by the Association for Professionals in Infection Control and Epidemiology (APIC). The award recognizes a healthcare facility's executive team member who has demonstrated significant support for infection prevention and control throughout their facility.

Friberg was honored during an APIC ceremony commemorating International Infection Prevention Week, (IIPW), held on October 16 at the National Press Club in Washington, DC, where APIC is headquartered. APIC members throughout the world viewed the program via live webcast. In receiving the award, Friberg was presented with a commemorative plaque and funding for educational products for her institution.

"We are proud to honor Deb with this award," said APIC 2009 President Christine J. Nutty, RN, MSN, CIC. "Her support has been integral to the success of WakeMed's infection prevention and control program. She has provided funding for research studies related to infection prevention and participated in state and national infection prevention collaboratives. She has also supported the addition of patient care products that while more expensive than those previously used, have been proven to help prevent infections. Not only does she provide both administrative and financial support to help the staff set and meet ambitious goals, but she also sets standards for physicians and employees by publicly displaying her commitment to infection prevention during interactions throughout the facility."

During her 14 years of leadership at WakeMed, an 810-bed not-for-profit system based in Raleigh, the infection prevention department has grown from a staff of two to a staff of seven and has become much more visible within the organization. Despite challenging economic times, Friberg recently approved the purchase of an electronic infection surveillance system to improve data collection and reduce staff time spent on surveillance and clerical tasks. Automated surveillance offers a more efficient and accurate means of obtaining healthcare-associated infection data and allows infection preventionists to improve prevention practices.

Recognizing that Methicillin-resistant Staphylococcus aureus (MRSA) infections are a major threat to their patients, Friberg has committed her time as the executive sponsor for MRSA reduction and leads the organization's participation in a three-year collaborative with 41 other hospitals. As a result, the system's MRSA rates have decreased by 54 percent since the project began in 2006. She also approved requests to begin active surveillance culturing to obtain quicker MRSA test results. Within two months of active surveillance screening and interventions that included strict hand hygiene and enhanced environmental cleaning, the facility eliminated MRSA transmission in their neonatal unit. The program was expanded to the adult trauma unit which has had no MRSA infections for more than a year.

When WakeMed infection preventionists wanted to study chlorhexidine bathing for surgical intensive care unit patients, Friberg approved the funding. Within three months, these measures reduced catheter-related blood stream infections by 74 percent. She also supported a project to place personal protective equipment at the point-of-use for healthcare workers along with significant funding to purchase rolling cabinets to house the equipment.

Hand hygiene compliance is another priority for Friberg. Under her leadership, hand hygiene has been added as a component of every employee's performance evaluation in addition to being named the organization's number one patient safety standard. The result: hand hygiene compliance rates have risen to 90 percent or better since January 2009.
-end-
IIPW takes place October 18-24 this year and carries the theme, "Infection prevention is everyone's business." With support from 3M Health Care through an unrestricted educational grant, APIC will offer a series of free webinars for health professionals October 20-22 on current issues in infection prevention. For additional information on IIPW activities, please visit www.apic.org/iipw.

APIC's mission is to improve health and patient safety by reducing risks of infection and other adverse outcomes. The association's more than 12,000 members direct infection prevention programs that save lives and improve the bottom line for hospitals and other healthcare facilities around the globe. To promote a culture within healthcare where targeting zero healthcare-associated infections is fully embraced, APIC has created the "Targeting Zero" initiative to accelerate both learning and delivery of practical tools for infection preventionists. APIC advances its mission through education, research, collaboration, practice guidance, public policy and credentialing. Visit APIC online at www.apic.org. For consumer-related information, visit www.preventinfection.org.

Association for Professionals in Infection Control

Related MRSA Articles from Brightsurf:

Widely available antibiotics could be used in the treatment of 'superbug' MRSA
Some MRSA infections could be tackled using widely-available antibiotics, suggests new research from an international collaboration led by scientists at the University of Cambridge and the Wellcome Sanger Institute.

Computer model shows how to better control MRSA outbreaks
A research team led by scientists at the Columbia University Mailman School of Public Health report on a new method to help health officials control outbreaks of methicillin-resistant Staphylococcus aureus, or MRSA, a life-threatening antibiotic-resistant infection often seen in hospitals.

Using MRSA's strength against it
MRSA evolved to become a deadly killer because it's wily and resilient.

Livestock-associated MRSAfound among MRSA from humans
The survey results show more frequent detections and geographical dispersion of LA-MRSA in humans in the EU/EEA since 2007, and highlight the public health and veterinary importance of LA-MRSA as a 'One Health' issue.

Fighting MRSA with new membrane-busting compounds
Public health officials are increasingly concerned over methicillin-resistant Staphylococcus aureus (MRSA).

Know thy enemy: Kill MRSA with tailored chemistry
UConn medicinal chemists have developed experimental antibiotics that kill MRSA, a common and often deadly bacteria that causes skin, lung, and heart infections.

MRSA uses decoys to evade a last-resort antibiotic
The superbug MRSA uses decoys to evade a last-resort antibiotic, reveals new research.

Scientists find a salty way to kill MRSA
Scientists have discovered a new way to attack Staphylococcus aureus bacteria.

Experimental antibiotic treats deadly MRSA infection
A new experimental antibiotic developed by a team of scientists at Rutgers University successfully treats the deadly MRSA infection and restores the efficacy of a commonly prescribed antibiotic that has become ineffective against MRSA.

OU team develops new antibiotic to fight MRSA
A University of Oklahoma team of chemists has developed a new antibiotic formulation to fight the sometimes deadly staph infection caused by methicillin-resistant S. aureus or MRSA and other antibiotic-resistant infectious bacteria.

Read More: MRSA News and MRSA Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.